These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 12682110)

  • 1. CD1d-expressing dendritic cells but not thymic epithelial cells can mediate negative selection of NKT cells.
    Chun T; Page MJ; Gapin L; Matsuda JL; Xu H; Nguyen H; Kang HS; Stanic AK; Joyce S; Koltun WA; Chorney MJ; Kronenberg M; Wang CR
    J Exp Med; 2003 Apr; 197(7):907-18. PubMed ID: 12682110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes.
    Nishimura T; Kitamura H; Iwakabe K; Yahata T; Ohta A; Sato M; Takeda K; Okumura K; Van Kaer L; Kawano T; Taniguchi M; Nakui M; Sekimoto M; Koda T
    Int Immunol; 2000 Jul; 12(7):987-94. PubMed ID: 10882410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted expression of human CD1d in transgenic mice reveals independent roles for thymocytes and thymic APCs in positive and negative selection of Valpha14i NKT cells.
    Schümann J; Pittoni P; Tonti E; Macdonald HR; Dellabona P; Casorati G
    J Immunol; 2005 Dec; 175(11):7303-10. PubMed ID: 16301636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells.
    Eberl G; Lees R; Smiley ST; Taniguchi M; Grusby MJ; MacDonald HR
    J Immunol; 1999 Jun; 162(11):6410-9. PubMed ID: 10352254
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand-dependent inhibition of CD1d-restricted NKT cell development in mice transgenic for the activating receptor Ly49D.
    Voyle RB; Beermann F; Lees RK; Schümann J; Zimmer J; Held W; MacDonald HR
    J Exp Med; 2003 Apr; 197(7):919-25. PubMed ID: 12682111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NIK-dependent RelB activation defines a unique signaling pathway for the development of V alpha 14i NKT cells.
    Elewaut D; Shaikh RB; Hammond KJ; De Winter H; Leishman AJ; Sidobre S; Turovskaya O; Prigozy TI; Ma L; Banks TA; Lo D; Ware CF; Cheroutre H; Kronenberg M
    J Exp Med; 2003 Jun; 197(12):1623-33. PubMed ID: 12810685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expansion and long-range differentiation of the NKT cell lineage in mice expressing CD1d exclusively on cortical thymocytes.
    Wei DG; Lee H; Park SH; Beaudoin L; Teyton L; Lehuen A; Bendelac A
    J Exp Med; 2005 Jul; 202(2):239-48. PubMed ID: 16027237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A natural killer T (NKT) cell developmental pathway iInvolving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage.
    Pellicci DG; Hammond KJ; Uldrich AP; Baxter AG; Smyth MJ; Godfrey DI
    J Exp Med; 2002 Apr; 195(7):835-44. PubMed ID: 11927628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cell maturation overrules H-2D-mediated natural killer T (NKT) cell inhibition: critical role for B7 in CD1d-dependent NKT cell interferon gamma production.
    Ikarashi Y; Mikami R; Bendelac A; Terme M; Chaput N; Terada M; Tursz T; Angevin E; Lemonnier FA; Wakasugi H; Zitvogel L
    J Exp Med; 2001 Oct; 194(8):1179-86. PubMed ID: 11602646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutting edge: influence of the TCR V beta domain on the avidity of CD1d:alpha-galactosylceramide binding by invariant V alpha 14 NKT cells.
    Schümann J; Voyle RB; Wei BY; MacDonald HR
    J Immunol; 2003 Jun; 170(12):5815-9. PubMed ID: 12794105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CD1d-binding glycolipid alpha-galactosylceramide enhances humoral immunity to T-dependent and T-independent antigen in a CD1d-dependent manner.
    Lang GA; Exley MA; Lang ML
    Immunology; 2006 Sep; 119(1):116-25. PubMed ID: 16792697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymocyte expression of cathepsin L is essential for NKT cell development.
    Honey K; Benlagha K; Beers C; Forbush K; Teyton L; Kleijmeer MJ; Rudensky AY; Bendelac A
    Nat Immunol; 2002 Nov; 3(11):1069-74. PubMed ID: 12368909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of hepatic NKT cells and subsequent liver injury following administration of alpha-galactosylceramide.
    Osman Y; Kawamura T; Naito T; Takeda K; Van Kaer L; Okumura K; Abo T
    Eur J Immunol; 2000 Jul; 30(7):1919-28. PubMed ID: 10940881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DOCK2 is required in T cell precursors for development of Valpha14 NK T cells.
    Kunisaki Y; Tanaka Y; Sanui T; Inayoshi A; Noda M; Nakayama T; Harada M; Taniguchi M; Sasazuki T; Fukui Y
    J Immunol; 2006 Apr; 176(8):4640-5. PubMed ID: 16585555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human NKT cells express granulysin and exhibit antimycobacterial activity.
    Gansert JL; Kiessler V; Engele M; Wittke F; Röllinghoff M; Krensky AM; Porcelli SA; Modlin RL; Stenger S
    J Immunol; 2003 Mar; 170(6):3154-61. PubMed ID: 12626573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interdependency of MHC class II/self-peptide and CD1d/self-glycolipid presentation by TNF-matured dendritic cells for protection from autoimmunity.
    Wiethe C; Schiemann M; Busch D; Haeberle L; Kopf M; Schuler G; Lutz MB
    J Immunol; 2007 Apr; 178(8):4908-16. PubMed ID: 17404272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to CD1d enhance thymic expression of invariant NKT TCR and increase the presence of NOD thymic invariant NKT cells.
    White TC; Chauhan V; Middlebrook AJ; Im JS; Deluca D
    Dev Comp Immunol; 2008; 32(8):943-56. PubMed ID: 18295332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of CD1d in postselection NKT cell maturation and homeostasis.
    McNab FW; Berzins SP; Pellicci DG; Kyparissoudis K; Field K; Smyth MJ; Godfrey DI
    J Immunol; 2005 Sep; 175(6):3762-8. PubMed ID: 16148122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine CD8
    Oh S; Lee H; Shin JH; Hong C; Park SH
    Immunol Invest; 2018 Jan; 47(1):89-100. PubMed ID: 29099628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypical and functional alterations during the expansion phase of invariant Valpha14 natural killer T (Valpha14i NKT) cells in mice primed with alpha-galactosylceramide.
    Ikarashi Y; Iizuka A; Koshidaka Y; Heike Y; Takaue Y; Yoshida M; Kronenberg M; Wakasugi H
    Immunology; 2005 Sep; 116(1):30-7. PubMed ID: 16108815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.